Matrifen 12 ug/h, Transdermales Pflaster
7680574600252
CH-57460
N02AB03
01.01.3.
Active substances:
1 / 3
google
Details
- GTIN
- 7680574600252
- Pharmacode
- -
- Product number
- 5746005
- CPT
- -
- Packaging group
- 10
- Unit
- Pflaster
- Composition
- fentanylum 1.38 mg, dipropylenglycolum, hydroxypropylcellulosum, silicone adhesive, dimeticonum 350, ethyleni et vinylis acetatis polymerisatum, Trägermaterial: poly(ethylenis terephthalas), Drucktinte: Orange, ad praeparationem pro 4.2 cm² cum liberatione 12.5 µg/h.
Articles (1)
Matrifen 12 ug/h, Transdermales Pflaster
Transdermales Pflaster
10
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
fentanylum
|
1.38 MG | Substance | Wirkstoff (Principe actif) |
|
dipropylenglycolum
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
hydroxypropylcellulosum
|
- | Substance | HNIDK |
|
silicone adhesive
|
- | Substance | HNIDK |
|
dimeticonum 350
|
- | Substance | HNIDK |
|
ethyleni et vinylis acetatis polymerisatum
|
- | Substance | HNIDK |
|
poly(ethylenis terephthalas)
|
- | Substance | HNIDK |
Authorization holder
Future Health Pharma GmbH
8620 Wetzikon ZH
Authorization information
- Swissmedic authorization number
- 57460
- Drug name
- Matrifen, Transdermales Pflaster
- Galenic form
- TRAP
- ATC Code
- N02AB03
- Authorization status
- Z
- Dispensation category
- A+
- First authorization
- 22/11/2007
- Authorization expiration date
- 31/12/9999
- IT number
- 01.01.3.
- Domain
- Human medicine
Packaging details
- Description (FR)
- MATRIFEN 12 ug/h empl 10 pce
- Description (DE)
- MATRIFEN 12 ug/h Pfl 10 Stk
- Market launch
- 09/02/2026
- Market withdrawal
- 11/02/2026
- Narcotic (BTM)
- A